Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+2.84M
-
Total reported value, excl. options
-
$2.46B
-
Value change
-
+$131M
-
Put/Call ratio
-
3.89
-
Number of buys
-
90
-
Number of sells
-
-84
-
Price
-
$46.20
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2018
220 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q1 2018.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 101M outstanding shares and own 52.77% of the company stock.
Largest 10 shareholders include FMR LLC (6.84M shares), VANGUARD GROUP INC (6.49M shares), BlackRock Inc. (5.91M shares), STATE STREET CORP (2.72M shares), Hillhouse Capital Management, Ltd. (2.6M shares), EcoR1 Capital, LLC (2M shares), JANUS HENDERSON GROUP PLC (1.98M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.95M shares), FARALLON CAPITAL MANAGEMENT LLC (1.72M shares), and FIRST TRUST ADVISORS LP (1M shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.